Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Operating Leases (2022 - 2025)

Historic Operating Leases for Evoke Pharma (EVOK) over the last 3 years, with Q3 2025 value amounting to $46381.0.

  • Evoke Pharma's Operating Leases changed N/A to $46381.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $46381.0, marking a year-over-year change of. This contributed to the annual value of $100958.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Evoke Pharma's Operating Leases is $46381.0.
  • Evoke Pharma's 5-year Operating Leases high stood at $100958.0 for Q4 2024, and its period low was $13371.0 during Q3 2022.
  • Over the past 3 years, Evoke Pharma's median Operating Leases value was $65028.0 (recorded in 2025), while the average stood at $61791.0.